| Robert E Bulow, DO | |
|
2350 Miami Valley Dr Ste 310, Centerville, OH 45459-4778 | |
| (937) 438-5216 | |
| (937) 438-5229 |
| Full Name | Robert E Bulow |
|---|---|
| Gender | Male |
| Speciality | Interventional Cardiology |
| Experience | 37 Years |
| Location | 2350 Miami Valley Dr Ste 310, Centerville, Ohio |
| Accepts Medicare Assignments | Yes. He accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1477552271 | NPI | - | NPPES |
| 000000009508 | Other | OH | ANTHEM |
| P00922092 | Other | OH | RAILROAD MEDICARE PIN |
| 0234517 | Medicaid | OH |
| Facility Name | Location | Facility Type |
|---|---|---|
| Miami Valley Hospital | Dayton, OH | Hospital |
| Upper Valley Medical Center | Troy, OH | Hospital |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Premier Health Specialists Inc | 5597708594 | 394 |
News Archive
New York Stem Cell Foundation (NYSCF)-Druckenmiller Fellow, Daylon James, PhD, of Weill Cornell Medial College, is lead author on a study defining conditions for generating a plentiful supply of endothelial (vessel lining) cells that are suitable for therapeutic use. Dr. James and his colleagues created a human embryonic stem cell (hESC) "reporter" line that can be used to measure endothelial cell production and activity.
Family therapy and other psychological treatments may help reduce symptoms of post-traumatic stress among teenaged survivors of childhood cancer-as well as among their parents.
Since she was a child, Katie Szymczak has had eyes that wandered. Her right eye, which was the worst, would look up and to the side, rather than straight ahead. Her husband affectionately called them "googly eyes." But other people could be mean. "They would say to me, 'What's wrong with your eyes, why aren't you looking at me?'" Szymczak said. "It really hurt a lot."
Tolerx, Inc., a biopharmaceutical company developing novel therapies to treat autoimmune diseases and cancer by modulating T cell activity, today announced that it has initiated a Phase 1 clinical trial to assess the safety, tolerability, pharmacokinetic, and pharmacodynamic profiles of TRX518, a monoclonal antibody designed to enhance the immune system by enabling T cells to more effectively attack cancer cells.
Tired of waiting for federal action to reduce prescription drug costs, Colorado is acting on its own — even if it must do so with one arm tied behind its back.
› Verified 6 days ago
| Entity Name | Alliance Physicians Inc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1437125572 PECOS PAC ID: 0840104360 Enrollment ID: O20031118000529 |
News Archive
New York Stem Cell Foundation (NYSCF)-Druckenmiller Fellow, Daylon James, PhD, of Weill Cornell Medial College, is lead author on a study defining conditions for generating a plentiful supply of endothelial (vessel lining) cells that are suitable for therapeutic use. Dr. James and his colleagues created a human embryonic stem cell (hESC) "reporter" line that can be used to measure endothelial cell production and activity.
Family therapy and other psychological treatments may help reduce symptoms of post-traumatic stress among teenaged survivors of childhood cancer-as well as among their parents.
Since she was a child, Katie Szymczak has had eyes that wandered. Her right eye, which was the worst, would look up and to the side, rather than straight ahead. Her husband affectionately called them "googly eyes." But other people could be mean. "They would say to me, 'What's wrong with your eyes, why aren't you looking at me?'" Szymczak said. "It really hurt a lot."
Tolerx, Inc., a biopharmaceutical company developing novel therapies to treat autoimmune diseases and cancer by modulating T cell activity, today announced that it has initiated a Phase 1 clinical trial to assess the safety, tolerability, pharmacokinetic, and pharmacodynamic profiles of TRX518, a monoclonal antibody designed to enhance the immune system by enabling T cells to more effectively attack cancer cells.
Tired of waiting for federal action to reduce prescription drug costs, Colorado is acting on its own — even if it must do so with one arm tied behind its back.
› Verified 6 days ago
| Entity Name | Premier Health Specialists Inc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1194958223 PECOS PAC ID: 5597708594 Enrollment ID: O20050610000010 |
News Archive
New York Stem Cell Foundation (NYSCF)-Druckenmiller Fellow, Daylon James, PhD, of Weill Cornell Medial College, is lead author on a study defining conditions for generating a plentiful supply of endothelial (vessel lining) cells that are suitable for therapeutic use. Dr. James and his colleagues created a human embryonic stem cell (hESC) "reporter" line that can be used to measure endothelial cell production and activity.
Family therapy and other psychological treatments may help reduce symptoms of post-traumatic stress among teenaged survivors of childhood cancer-as well as among their parents.
Since she was a child, Katie Szymczak has had eyes that wandered. Her right eye, which was the worst, would look up and to the side, rather than straight ahead. Her husband affectionately called them "googly eyes." But other people could be mean. "They would say to me, 'What's wrong with your eyes, why aren't you looking at me?'" Szymczak said. "It really hurt a lot."
Tolerx, Inc., a biopharmaceutical company developing novel therapies to treat autoimmune diseases and cancer by modulating T cell activity, today announced that it has initiated a Phase 1 clinical trial to assess the safety, tolerability, pharmacokinetic, and pharmacodynamic profiles of TRX518, a monoclonal antibody designed to enhance the immune system by enabling T cells to more effectively attack cancer cells.
Tired of waiting for federal action to reduce prescription drug costs, Colorado is acting on its own — even if it must do so with one arm tied behind its back.
› Verified 6 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Robert E Bulow, DO 3170 Kettering Blvd Bldg B3, Moraine, OH 45439-1924 Ph: (937) 991-3188 | Robert E Bulow, DO 2350 Miami Valley Dr Ste 310, Centerville, OH 45459-4778 Ph: (937) 438-5216 |
News Archive
New York Stem Cell Foundation (NYSCF)-Druckenmiller Fellow, Daylon James, PhD, of Weill Cornell Medial College, is lead author on a study defining conditions for generating a plentiful supply of endothelial (vessel lining) cells that are suitable for therapeutic use. Dr. James and his colleagues created a human embryonic stem cell (hESC) "reporter" line that can be used to measure endothelial cell production and activity.
Family therapy and other psychological treatments may help reduce symptoms of post-traumatic stress among teenaged survivors of childhood cancer-as well as among their parents.
Since she was a child, Katie Szymczak has had eyes that wandered. Her right eye, which was the worst, would look up and to the side, rather than straight ahead. Her husband affectionately called them "googly eyes." But other people could be mean. "They would say to me, 'What's wrong with your eyes, why aren't you looking at me?'" Szymczak said. "It really hurt a lot."
Tolerx, Inc., a biopharmaceutical company developing novel therapies to treat autoimmune diseases and cancer by modulating T cell activity, today announced that it has initiated a Phase 1 clinical trial to assess the safety, tolerability, pharmacokinetic, and pharmacodynamic profiles of TRX518, a monoclonal antibody designed to enhance the immune system by enabling T cells to more effectively attack cancer cells.
Tired of waiting for federal action to reduce prescription drug costs, Colorado is acting on its own — even if it must do so with one arm tied behind its back.
› Verified 6 days ago
Shahila Navayogarajah, MD Internal Medicine Medicare: Accepting Medicare Assignments Practice Location: 7457 Pelbrook Farm Dr, Centerville, OH 45459 Phone: 937-435-4643 | |
Dr. Kavitha Aluri Choudary, M.D. Internal Medicine Medicare: Accepting Medicare Assignments Practice Location: 7073 Clyo Rd, Centerville, OH 45459 Phone: 937-435-5857 Fax: 937-912-4960 | |
Dr. Sarah M Hedrick, M.D. Internal Medicine Medicare: Accepting Medicare Assignments Practice Location: 6661 Clyo Rd, Centerville, OH 45459 Phone: 937-425-4000 Fax: 937-425-4002 | |
Gary John Palmer, M.D. Internal Medicine Medicare: Accepting Medicare Assignments Practice Location: 7073 Clyo Rd, Centerville, OH 45459 Phone: 937-435-5857 Fax: 937-912-4960 | |
Dr. Jhansi L Koduri, MD Internal Medicine Medicare: Accepting Medicare Assignments Practice Location: 2300 Miami Valley Dr Ste 150, Centerville, OH 45459 Phone: 937-293-1622 Fax: 937-245-6308 | |
Dr. William Earl Venanzi Jr., MD Internal Medicine Medicare: Accepting Medicare Assignments Practice Location: 1989 Miamisburg Centerville Rd Ste 301, Centerville, OH 45459 Phone: 937-434-7353 Fax: 937-438-6569 | |
Gary J Fishbein, MD Internal Medicine Medicare: Accepting Medicare Assignments Practice Location: 2350 Miami Valley Dr Ste 310, Centerville, OH 45459 Phone: 937-277-4274 Fax: 937-277-8476 |